Breaking News
Ad-Free Version. Upgrade your experience. Save up to 40% More details

CVS: Efficiency could Bolster Dividend Payouts

Stock MarketsSep 19, 2021 10:31AM ET
Saved. See Saved Items.
This article has already been saved in your Saved Items
© Reuters. CVS: Efficiency could Bolster Dividend Payouts

CVS Health Corporation (NYSE:CVS) is a U.S.-based pharmacy chain with offerings throughout the entire health care spectrum. CVS stock is heavily backed by Michael Burry and has gained by more than 25% year to date. I am bullish on the stock.

Sales Growth

CVS recorded a sublime second quarter, with year-over-year revenue growth of 11.1%. The group benefited from continued Government service business and a 13.80% year-over-year increase in Medical Memberships.

According to the group's CEO, Karen Lynch, "This quarter was highlighted by broad sales and earnings outperformance, as well as sequential operating margin improvement."

Operating Efficiency

I directed the headline numbers and found CVS' operating efficiency to be the catalyst for its strong numbers. Since June 2020, the company's days of sales outstanding have decreased by 1.63, while its operating margin has increased by 1.96%. These factors have contributed to an improved year-to-date interest coverage ratio (+21%), subsequently opening up larger after-interest margins for equity holders to benefit from.

Finally, CVS' net income margin (2.60%) and cash from operations ($14.18 billion) are at a five-year high, which may lead to a dividend payout increase.

Dividend Capacity

I believe CVS has plenty of dividend capacity, especially since it has suspended its share repurchase program and decided to compensate investors with dividends only. With dividends already yielding 2.34%, CVS stock has a free cash flow yield to dividend yield ratio (4.42%) that exceeds its 5-year median by 10.44%. It also has a payout ratio that is still 15.20% lower than its 5-year average.

If we consider these ratios out of isolation and look at CVS's profitability, it would be impossible to think its dividend capacity isn't increasing.

Wall Street's Take

Average CVS price target is $100.50, with a 17.5% upside.

Wall Street thinks the stock is a Strong Buy, with 9 Buy and 1 Hold ratings, and that it will reach the $100 handle within the next 12-months. 5-star analyst Ricky Goldwasser of Morgan Stanley (NYSE:MS) placed the latest and highest price target of $114 on the stock, citing underappreciated cost-cutting and capital deployment as her main reasons.

Concluding Thoughts

CVS looks good all around. Its high-quality and sustainable topline revenue is being accommodated with operational efficiency, which could lead to both capital gains and strong dividend income for investors.

Disclosure: At the time of publication, Steve Gray Booyens had a long position in CVS.

Disclaimer: The information contained in this article represents the views and opinion of the writer only, and not the views or opinion of Tipranks or its affiliates, and should be considered for informational purposes only. Tipranks makes no warranties about the completeness, accuracy or reliability of such information. Nothing in this article should be taken as a recommendation or solicitation to purchase or sell securities. Nothing in the article constitutes legal, professional, investment and/or financial advice and/or takes into account the specific needs and/or requirements of an individual, nor does any information in the article constitute a comprehensive or complete statement of the matters or subject discussed therein. Tipranks and its affiliates disclaim all liability or responsibility with respect to the content of the article, and any action taken upon the information in the article is at your own and sole risk. The link to this article does not constitute an endorsement or recommendation by Tipranks or its affiliates. Past performance is not indicative of future results, prices or performance.

CVS: Efficiency could Bolster Dividend Payouts

Related Articles

Facebook plans to change its name - The Verge
Facebook plans to change its name - The Verge By Reuters - Oct 19, 2021 5

(Reuters) -Social media giant Facebook Inc (NASDAQ:FB) is planning to rebrand itself with a new name next week, the Verge reported on Tuesday, citing a source with direct...

Bitcoin sits below all-time high after U.S. ETF debut
Bitcoin sits below all-time high after U.S. ETF debut By Reuters - Oct 20, 2021

HONG KONG (Reuters) - Bitcoin hovered below record levels on Wednesday, the day after the first U.S. bitcoin futures-based exchange-traded fund (ETF) began trading, a development...

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at’s discretion.

Write your thoughts here
Are you sure you want to delete this chart?
Post also to:
Replace the attached chart with a new chart ?
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Are you sure you want to delete this chart?
Replace the attached chart with a new chart ?
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
Sign up with Email